Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
暂无分享,去创建一个
Michael K Parides | D. Charney | M. aan het Rot | D. Iosifescu | K. Lapidus | J. Murrough | A. Feder | Dennis S Charney | M. Parides | Dan Iosifescu | J. Morgan | James W Murrough | Adriana Feder | Andrew M Perez | Julia E Morgan | Shireen Saxena | Katherine Kirkwood | Marije Aan Het Rot | Kyle A B Lapidus | Le-Ben Wan | Katherine A. Kirkwood | Shireen Saxena | Le-Ben Wan | A. M. Perez | S. Saxena
[1] R. A. Sewell,et al. Transient Resolution of Treatment-Resistant Posttraumatic Stress Disorder Following Ketamine Infusion , 2013, Biological Psychiatry.
[2] D. Charney,et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. , 2013, The American journal of psychiatry.
[3] D. Luckenbaugh,et al. Acute Stress Symptoms Do Not Worsen in Posttraumatic Stress Disorder and Abuse with a Single Subanesthetic Dose of Ketamine , 2013, Biological Psychiatry.
[4] G. Aghajanian,et al. Synaptic Dysfunction in Depression: Potential Therapeutic Targets , 2012, Science.
[5] Zhen Yan,et al. Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex , 2012, Neuron.
[6] M. Perez-Rodriguez,et al. New perspectives in glutamate and anxiety , 2012, Pharmacology Biochemistry and Behavior.
[7] Thomas Steckler,et al. Pharmacological treatment of PTSD – Established and new approaches , 2012, Neuropharmacology.
[8] F. López-Muñoz,et al. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs. , 2011, Journal of anxiety disorders.
[9] Nanxin Li,et al. Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure , 2011, Biological Psychiatry.
[10] Nanxin Li,et al. mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.
[11] M. Stein,et al. Pharmacotherapy of PTSD: Premises, principles, and priorities , 2009, Brain Research.
[12] Lewis S. Nelson,et al. Adverse events associated with ketamine for procedural sedation in adults. , 2008, The American journal of emergency medicine.
[13] J. Nair,et al. The Role of the Glutamatergic System in Posttraumatic Stress Disorder , 2008, CNS Spectrums.
[14] I. Black,et al. The correlation between ketamine and posttraumatic stress disorder in burned service members. , 2008, The Journal of trauma.
[15] M. Hautzinger,et al. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims , 2008, Journal of psychopharmacology.
[16] Paul J Carlson,et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.
[17] M. Hautzinger,et al. Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims , 2005, Psychopharmacology.
[18] L. Davis,et al. Clonazepam for Treatment of Sleep Disturbances Associated with Combat-Related Posttraumatic Stress Disorder , 2004, The Annals of pharmacotherapy.
[19] D. Kupfer,et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. , 2004, Controlled clinical trials.
[20] J. Markowitz,et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression , 2003, Biological Psychiatry.
[21] Erica Duncan,et al. Clinical and Sensorimotor Gating Effects of Ketamine in Normals , 2001, Neuropsychopharmacology.
[22] R. Kessler,et al. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. , 1998, Archives of general psychiatry.
[23] R. Kessler,et al. Posttraumatic stress disorder in the National Comorbidity Survey. , 1995, Archives of general psychiatry.
[24] M. Linden,et al. Anaesthesia for urological endoscopic procedures in adult outpatients. , 1995, European journal of anaesthesiology.
[25] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[26] S. Dubovsky. Approaches to developing new anxiolytics and antidepressants. , 1993, The Journal of clinical psychiatry.
[27] B. Lerer,et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. , 1990, The Journal of clinical psychiatry.
[28] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[29] R. C. Young,et al. A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.
[30] S. Mathew,et al. Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence , 2016 .
[31] B. Capehart,et al. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications. , 2012, Journal of rehabilitation research and development.
[32] Helena Motlagh,et al. Impact of Event Scale-revised. , 2010, Journal of physiotherapy.
[33] J. Davidson,et al. Clinician‐administered PTSD scale: A review of the first ten years of research , 2001, Depression and anxiety.
[34] S. Southwick,et al. Measurement of Dissociative States with the Clinician-Administered Dissociative States Scale (CADSS) , 1998, Journal of traumatic stress.
[35] John-Paul Wilson,et al. Assessing psychological trauma and PTSD , 1997 .
[36] S. Dubovsky. Approaches to developing new anxiolytics and antidepressants : Anxiety : special problems and new approaches , 1993 .
[37] J. Overall. The brief psychiatric rating scale (BPRS) : Recent developments in ascertainment and scaling. Introduction , 1988 .